DOCTORAL THESIS. Investigation of patients suspected of having urinary bladder cancer is resource-intensive. Often, it requires a camera examination through the urethra, which can cause discomfort and complications. Suleiman Abuhasanein’s thesis reveals new and rapid methods for early detection of this cancer form, potentially reducing costs for society and suffering for patients. A new urine test and an innovative AI technique can simplify the investigation of bladder cancer. That’s what…
Basic research saves lives in children with high-risk neuroblastoma
NEW STUDY. Thanks to many years of basic research into the rare cancer neuroblastoma, some very seriously ill children can now be returned to health. The treatment is simple, has significantly fewer side effects, and has a surprisingly fast effect. A major European collaboration, which includes researchers at the University of Gothenburg and Karolinska Institutet, has now published its results in the Journal of Clinical Oncology. It will have a…
Long sick leave after low-grade brain tumor
STUDY. One year after the diagnosis of low-grade malignant brain tumor, a University of Gothenburg study shows, just under three people in ten were in full-time employment. Another year later, the proportion remained below half. For this young patient group, returning to work is a key health factor. Every year, some 100 people in Sweden are diagnosed with low-grade brain tumor (also known as low-grade glioma). This type of tumor…
Ruth Palmer named Cancer Researcher of the Year 2019 – see her attendance during the gala in TV4
APPOINTMENT. The other night, during the live TV-gala ‘Together Against Cancer’ in TV4, Ruth Plmers was appointed Cancer Researcher of the Year by the Cancer Foundation’s research board. Ruth Palmer, Professor of Molecular Cell Biology at Sahlgrenska Academy aims to find new treatment methods for neuroblastoma, a cancer that primarily affects children. The TV-gala Tillsammans mot cancer (‘Together Against Cancer’) was broadcasted live nationwide on Monday, January 7, 2019. You…
Immunotherapy saves many lives – but could help even more people
RESEARCH. This year’s Nobel Laureates in Medicine have revolutionized the treatment of cancer with immunotherapy, which means that one out of five patients with metastatic skin cancer can be cured. But half of the patients with metastatic malignant melanoma are not helped by the new treatment. Researchers at the Sahlgrenska Cancer Center and on the Melanoma Team at Sahlgrenska University Hospital are working together in an attempt to understand why…